Explore Purple Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PPBT. Purple Biotech shares are trading lower by 28% during Tuesday's session.

To report any concerns or inaccuracies, please contact us at [email protected]. The post PPBT Stock Earnings: Purple Biotech Beats EPS for Q2 2024 appeared first on InvestorPlace.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

it received an extension of 180 calendar days from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with the Nasdaq’s minimum $1.00 bid price ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

YTD Price Performance:-1.74% Average Trading Volume: 939,418 Technical Sentiment Consensus Rating: Sell Current Market Cap: $12.33M See more insights into PPBT stock on TipRanks’ Stock Analysis ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Purple Biotech stock opened at $2.98 on Monday ... HC Wainwright reiterated a “buy” rating and issued a $33.00 target price on shares of Purple Biotech in a report on Friday ...